Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suboxone micro-dosing for postoperative pain in opioid-tolerant patients
NCT04771689Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2022
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Suboxone in postoperative pain, sponsored by Massachusetts General Hospital. Primary endpoints: Postoperative Pain Scores at 6 days and Postoperative Opioid Consumption at 6 days. Planned start Jul 2022; status: withdrawn.
02
Drugs
Suboxone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04771689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04771689.